487 related articles for article (PubMed ID: 2168269)
1. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
Wang RB; Liu LT; Yiu CH; Chang TY
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of carbamazepine and its epoxide and diol metabolites in epileptic patients: the influence of dose and comedication.
Rambeck B; May T; Juergens U
Ther Drug Monit; 1987 Sep; 9(3):298-303. PubMed ID: 3672573
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing simultaneous concentrations of total and free carbamazepine and carbamazepine-10, 11-epoxide in serum of children with epilepsy.
Elyas AA; Patsalos PN; Agbato OA; Brett EM; Lascelles PT
Ther Drug Monit; 1986; 8(3):288-92. PubMed ID: 3750372
[TBL] [Abstract][Full Text] [Related]
4. Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedication.
Svinarov DA; Pippenger CE
Ther Drug Monit; 1996 Dec; 18(6):660-5. PubMed ID: 8946662
[TBL] [Abstract][Full Text] [Related]
5. Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants.
Brodie MJ; Forrest G; Rapeport WG
Br J Clin Pharmacol; 1983 Dec; 16(6):747-9. PubMed ID: 6661364
[TBL] [Abstract][Full Text] [Related]
6. Carbamazepine and carbamazepine-10,11-epoxide serum concentrations in epileptic children.
Furlanut M; Montanari G; Bonin P; Casara GL
J Pediatr; 1985 Mar; 106(3):491-5. PubMed ID: 3973787
[TBL] [Abstract][Full Text] [Related]
7. Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy.
Ramsay RE; McManus DQ; Guterman A; Briggle TV; Vazquez D; Perchalski R; Yost RA; Wong P
Ther Drug Monit; 1990 May; 12(3):235-41. PubMed ID: 2112276
[TBL] [Abstract][Full Text] [Related]
8. Routine therapeutic monitoring of the active metabolite of carbamazepine: Is it really necessary?
Burianová I; Bořecká K
Clin Biochem; 2015 Sep; 48(13-14):866-9. PubMed ID: 26018946
[TBL] [Abstract][Full Text] [Related]
9. The influence of polytherapy on the relationships between serum carbamazepine and its metabolites in epileptic children.
Liu H; Delgado MR
Epilepsy Res; 1994 Mar; 17(3):257-69. PubMed ID: 8013448
[TBL] [Abstract][Full Text] [Related]
10. Carbamazepine and lamotrigine plasma concentrations in epileptic patients during optimising therapy.
Krasniqi S; Neziri B; Islami H; Bauer S
Med Arh; 2010; 64(2):80-3. PubMed ID: 20514770
[TBL] [Abstract][Full Text] [Related]
11. Lateral gaze nystagmus in carbamazepine-treated epileptic patients: correlation with total and free plasma concentrations of parent drug and its 10,11-epoxide metabolite.
Riva R; Contin M; Albani F; Perucca E; Ambrosetto G; Procaccianti G; Santucci M; Baruzzi A
Ther Drug Monit; 1985; 7(3):277-82. PubMed ID: 4049464
[TBL] [Abstract][Full Text] [Related]
12. Carbamazepine-10,11-epoxide in therapeutic drug monitoring.
Potter JM; Donnelly A
Ther Drug Monit; 1998 Dec; 20(6):652-7. PubMed ID: 9853982
[TBL] [Abstract][Full Text] [Related]
13. Intradose and circadian variation in circulating carbamazepine and its epoxide in epileptic patients: a consequence of autoinduction of metabolism.
Macphee GJ; Butler E; Brodie MJ
Epilepsia; 1987; 28(3):286-94. PubMed ID: 3582293
[TBL] [Abstract][Full Text] [Related]
14. Influence of carbamazepine-10,11-epoxide on the serum level of valproic acid in epileptic patients on combined treatment with carbamazepine and valproic acid.
Minkova GD; Getova DP
Folia Med (Plovdiv); 2000; 42(3):16-9. PubMed ID: 11347330
[TBL] [Abstract][Full Text] [Related]
15. Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy.
Semah F; Gimenez F; Longer E; Laplane D; Thuillier A; Baulac M
Ther Drug Monit; 1994 Dec; 16(6):537-40. PubMed ID: 7878690
[TBL] [Abstract][Full Text] [Related]
16. Interactions of phenobarbital and phenytoin with carbamazepine and its metabolites' concentrations, concentration ratios, and level/dose ratios in epileptic children.
Liu H; Delgado MR
Epilepsia; 1995 Mar; 36(3):249-54. PubMed ID: 7614908
[TBL] [Abstract][Full Text] [Related]
17. Developmental and therapeutic pharmacology of antiepileptic drugs.
Miura H
Epilepsia; 2000; 41 Suppl 9():2-6. PubMed ID: 11156504
[TBL] [Abstract][Full Text] [Related]
18. Improved therapeutic monitoring of drug interactions in epileptic children using carbamazepine polytherapy.
Liu H; Delgado MR
Ther Drug Monit; 1994 Apr; 16(2):132-8. PubMed ID: 8009559
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopharmacologic study of blood carbamazepine levels in a group of epileptic patients].
Testa G; Ermani M; Giaretta D; Pellegrini A; Paleari C
Riv Neurol; 1980; 50(4):241-52. PubMed ID: 7466220
[TBL] [Abstract][Full Text] [Related]
20. Relative proportions of serum carbamazepine and its pharmacologically active 10,11-epoxy derivative: effect of polytherapy and renal insufficiency.
Tutor-Crespo MJ; Hermida J; Tutor JC
Ups J Med Sci; 2008; 113(2):171-80. PubMed ID: 18509811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
